Combating Illicit Xylazine Act
Rep. Jimmy Panetta (D-CA) sponsored this bill, which adds xylazine (also known as tranq) to Schedule III of the Controlled Substances Act, making it illegal to manufacture, distribute, or possess with intent to distribute for illicit use, with criminal penalties enforced under existing drug laws. The bill requires xylazine transactions to be tracked in the DEA's drug reporting system (ARCOS) and exempts veterinarians, pharmacies, and wildlife programs that dispense xylazine lawfully for animal use from registration requirements. The bill also directs the Sentencing Commission to review and recommend appropriate sentencing guidelines for xylazine offenses and requires the DEA and FDA to report to Congress on the prevalence, impact, and trafficking of illicit xylazine in the United States. The bill passed with broad bipartisan support (114 cosponsors: 51 Democrats and 63 Republicans) and was placed on the Union Calendar in September 2026.
What’s in the bill (6 sections)
- Sec. 2. Definitions
- Sec. 3. Adding xylazine to schedule iii
- Sec. 4. Amendments
- Sec. 5. Arcos tracking
- Sec. 6. Sentencing commission
- Sec. 7. Report to congress on xylazine
Where it is in the process
Community vote
How readers of ThePolitibase feel about this bill. Reader sentiment only — not a scientific poll, and not a measure of public opinion.
District map
Sponsor
Cosponsors (114)
Activity timeline
Sep 16
Sep 15
Sep 15
Sep 15
Sep 15
Sep 15
Sep 15
Sep 14
Sep 14
Sep 14
Full action log
All 114 cosponsors
In the news
One email when they vote against their own party. Nothing else.